Medmix AG (CHIX:MEDXZ) Beta: 1.1263 (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:MEDXZ Medmix AG CHIX:MEDXZ
66 GF Score
Price CHF8.54
GF Value CHF9.05
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Medmix AG Beta?

Medmix AG CHIX:MEDXZ +1.97% 66 Beta is 1.1263 as of Jul. 31, 2026. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 66/100 and a GF Value™ of CHF9.05 (Fairly Valued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-31), Medmix AG's Beta is 1.1263.


Medmix AG  (CHIX:MEDXz) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Medmix AG Beta Related Terms


Medmix AG Beta Historical Data

* Premium members only.

The historical data trend for Medmix AG's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medmix AG Beta Chart

Medmix AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 1.04 1.54

Medmix AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.04 1.47 1.54 0.00

CHIX:MEDXZ vs GEV, ETN, PH: Beta Comparison

For the Specialty Industrial Machinery subindustry, Medmix AG's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medmix AG Beta vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Medmix AG's Beta distribution charts can be found below:

* The bar in red indicates where Medmix AG's Beta falls into.


CHIX:MEDXZ
66GF Score
Medmix AG CHIX:MEDXZ
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medmix AG Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.1263 mean?
Medmix AG (CHIX:MEDXZ) has a Beta of 1.1263 as of Jul. 31, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medmix AG and its competitors.
Is Medmix AG's Beta too high?
Medmix AG's current Beta is 1.1263. Overall, Medmix AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Beta compare to GEV and ETN?
Medmix AG's Beta of 1.1263 can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for an Industrial Products company?
A good Beta depends on the Industrial Products industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medmix AG and its competitors. Medmix AG's current Beta is 1.1263. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.05, compared to a current price of CHF8.54 — trading 5.7% below its estimated fair value. The current Beta is 1.1263. Medmix AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current Beta is 1.1263 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?

Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued. The current stock price of CHF8.54 is trading 5.7% below its estimated GF Value™ of CHF9.05. GuruFocus considers Medmix AG to be Fairly Valued.

Key valuation signals for CHIX:MEDXZ:

  • Beta: 1.1263
  • GF Value™: CHF9.05 vs. price of CHF8.54 (5.7% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medmix AG Business Description

Other Exchanges MEDX:Switzerland
Address Neuhofstrasse 20, Baar, CHE, 6340
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
66GF Score

Get the complete analysis for CHIX:MEDXZ

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF8.54
Price
CHF9.05
GF Value